209 Items, 11 Pages <<Prev 2 3 4 5 6 7 8 9 10 11 Next>> All
| No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
|---|---|---|---|---|---|---|
| 141 | Nucleotides:Dihydroorotate | Nucleotides | Biochemical examination | Clinical characteristics | Reference | 1 |
| 142 | Number of Digital rectal exams in past 5 yr | Digital rectal exams(DRE) | Accessory examination | Clinical characteristics | No statistical significance factor | 1 |
| 143 | Number of metabolic factors present | Metabolic factors | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
| 144 | Number of prostate specific antigen tests in past 5 yr | Prostate specific antigen tests | Accessory examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 145 | Obese | Obese | Diseases | Clinical characteristics | Risk factor No statistical significance factor | 2 |
| 146 | oleate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 147 | Other cholesterol-lowering drugs | Cholesterol-lowering drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 148 | Other H2 blockers | Antiulcer drug | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 149 | Other STD | STD | Diseases | Clinical characteristics | No statistical significance factor | 1 |
| 150 | palmitate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 151 | palmitoleate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 152 | Parathyroid Hormone | Clinical thyroid status | Biochemical examination | Clinical characteristics | No statistical significance factor | 2 |
| 153 | pentadecanoate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 154 | phenol sulfate | Metabolic factors | Biochemical examination | Clinical characteristics | Risk factor | 1 |
| 155 | phenylalanine | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 156 | phenylalanylleucine | Metabolic factors | Biochemical examination | Clinical characteristics | Risk factor | 1 |
| 157 | phenylalanyltryptophan | Metabolic factors | Biochemical examination | Clinical characteristics | Risk factor | 1 |
| 158 | Plasma concentration | Plasma concentration | Biochemical examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 159 | Plasma growth hormone | Hormone | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
| 160 | Pre-eclampsia or eclampsia | Eclampsia | Diseases | Clinical characteristics | No statistical significance factor | 1 |